Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma.
Djebbari F. et al, (2019), Br J Haematol, 186, e191 - e195
Phase 3 International Trial of Adjuvant Whole Brain Radiotherapy (WBRT) or Observation (OBS) Following Local Treatment of 1-3 Melanoma Brain Metastases (MBMs)
Fogarty GB. et al, (2019), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105, S139 - S140
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.
de Santiago I. et al, (2019), Int J Cancer, 145, 1125 - 1137
Adjuvant whole brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicentre, randomized phase 3 trial
MIDDLETON M. et al, (2019), Journal of Clinical Oncology
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan.
Lo SN. et al, (2019), Trials, 20
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
Kesavan M. et al, (2019), Curr Hematol Malig Rep, 14, 207 - 218
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Scarisbrick JJ. et al, (2019), Br J Dermatol, 181, 350 - 357
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.
Banerji U. et al, (2019), Lancet Oncol, 20, 1124 - 1135
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trials.
Howells L. et al, (2019), Psychooncology, 28, 1362 - 1366
The T cell architecture of pancreatic ductal adenocarcinoma.
Sivakumar S. et al, (2019), Annals of oncology : official journal of the European Society for Medical Oncology, 30 Suppl 4, iv64 - iv64
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma.
Andtbacka RHI. et al, (2019), J Immunother Cancer, 7
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).
Lebbe C. et al, (2019), Eur J Cancer, 114, 117 - 127
IMMUNOTHERAPY-RELATED GASTRITIS IN A TERTIARY ONCOLOGY CENTRE
Cheung V. et al, (2019), GUT, 68, A147 - A148
Germline selection shapes human mitochondrial DNA diversity.
Wei W. et al, (2019), Science (New York, N.Y.), 364
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine-resistance in breast cancer
Morotti M. et al, (2019), Proceedings of the National Academy of Sciences of the United States of America
An analysis of nivolumab-mediated adverse events and association with clinical efficacy in resected stage III or IV melanoma (CheckMate 238).
Mandala M. et al, (2019), JOURNAL OF CLINICAL ONCOLOGY, 37
An open label, multicenter, phase I/II study of RP1 as a single agent and in combination with PD1 blockade in patients with solid tumors.
Middleton MR. et al, (2019), JOURNAL OF CLINICAL ONCOLOGY, 37
Pharmacodynamic effect of IMCgp100 (TCR CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma.
Middleton MR. et al, (2019), JOURNAL OF CLINICAL ONCOLOGY, 37